Dendritic spine pathology in neuropsychiatric disorders
Open accessAbstract
Substantial progress has been made toward understanding the genetic architecture, cellular substrates, brain circuits and endophenotypic profiles of neuropsychiatric disorders, including autism spectrum disorders (ASD), schizophrenia and Alzheimer's disease. Recent evidence implicates spiny synapses as important substrates of pathogenesis in these disorders. Although synaptic perturbations are not the only alterations relevant for these diseases, understanding the molecular underpinnings of spine pathology may provide insight into their etiologies and may reveal new drug targets. Here we discuss recent neuropathological, genetic, molecular and animal model studies that implicate structural alterations at spiny synapses in the pathogenesis of major neurological disorders, focusing on ASD, schizophrenia and Alzheimer's disease as representatives of these categories across different ages of onset. We stress the importance of reverse translation, collaborative and multidisciplinary approaches, and the study of the spatio-temporal roles of disease molecules in the context of synaptic regulatory pathways and neuronal circuits that underlie disease endophenotypes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 161 cited sources checked · 0 supported · 0 flagged
- Premisecitation
A reduction in superior temporal gyrus gray matter volume is one of the most consistently reported alterations in schizophrenia.
“A reduction in superior temporal gyrus gray matter volume is one of the most consistently reported alterations in the schizophrenia brain14.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Yoshida, T. et al. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr. Res. 113, 84–94 (2009). source
Not checked in the free run.
- Premisecitation
Individuals with schizophrenia show a profound reduction in spine density on pyramidal neurons in the superior temporal gyrus, particularly in the primary auditory cortex.
“At the cellular level, individuals with schizophrenia show a profound reduction in spine density on pyramidal neurons in the superior temporal gyrus, particularly in the primary auditory cortex15.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Sweet, R.A., Henteleff, R.A., Zhang, W., Sampson, A.R. & Lewis, D.A. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 34, 374–389 (2009). source
Not checked in the free run.
- Premisecitation
Postmortem tissue from patients with Alzheimer's disease consistently shows prominent synapse loss.
“Studies analyzing postmortem tissue samples from patients diagnosed with Alzheimer’s disease consistently report prominent synapse loss7,18.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789–791 (2002). source
Not checked in the free run.
- cites [18] DeKosky, S.T. & Scheff, S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457–464 (1990). source
Not checked in the free run.
- Interpretationreasoning
In schizophrenia, brain region-specific gray matter loss, reduced spine density, and functional hypoactivity are strongly associated.
“Collectively, these studies reveal strong associations between brain region–specific loss of gray matter, reduced spine density and functional hypoactivity in schizophrenia.”
Quote in the paperSubstantial claim - Premisecitation
Postmortem studies support the view that spine density changes directly contribute to gray matter loss in schizophrenia.
“Several postmortem studies have examined spine density changes in brain regions showing the greatest indices of gray matter loss in schizophrenia and these results support the view that spine density changes directly contribute to gray matter loss in the disease3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Selemon, L.D. & Goldman-Rakic, P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17–25 (1999). source
Not checked in the free run.
- Premisecitation
In ASD post-mortem tissue, spine density is inversely correlated with cognitive function.
“Spine density was inversely correlated with cognitive function.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Hutsler, J.J. & Zhang, H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309, 83–94 (2010). source
Not checked in the free run.
- Premisecitation
Recent studies support altered synaptic connectivity and plasticity in the brains of individuals with ASD, schizophrenia, and Alzheimer's disease.
“recent studies support altered synaptic connectivity and plasticity in the brains of affected individuals3–6.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [3] Selemon, L.D. & Goldman-Rakic, P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17–25 (1999). source
Not checked in the free run.
- cites [4] Hutsler, J.J. & Zhang, H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309, 83–94 (2010). source
Not checked in the free run.
- cites [5] Glantz, L.A. & Lewis, D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65–73 (2000). source
Not checked in the free run.
- cites [6] Tackenberg, C., Ghori, A. & Brandt, R. Thin, stubby or mushroom: spine pathology in Alzheimer's disease. Curr. Alzheimer Res. 6, 261–268 (2009). source
Not checked in the free run.
- Premisecitation
Dendritic spine loss is observed in the hippocampus and throughout the cortex in Alzheimer's disease.
“Dendritic spine loss is observed in the hippocampus and throughout the cortex, the principal areas affected by Alzheimer’s disease–related pathology18,19.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [18] DeKosky, S.T. & Scheff, S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457–464 (1990). source
Not checked in the free run.
- cites [19] Walsh, D.M. & Selkoe, D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181–193 (2004). source
Not checked in the free run.
- Premisecitation
Spine loss in the dorsolateral prefrontal cortex has been reported in schizophrenia, particularly in layer 3 neurons.
“Indeed, spine loss in the DLPFC has been reported, particularly in layer 3 neurons5.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Glantz, L.A. & Lewis, D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65–73 (2000). source
Not checked in the free run.
- Interpretationcitation
The ASD post-mortem spine findings are consistent with the hypothesis that ASD brains show local hyperconnectivity and between-region hypoconnectivity.
“Such findings are consistent with an emerging hypothesis that the brains of individuals with ASD are characterized by hyperconnectivity in local circuits and hypoconnectivity between brain regions10.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Geschwind, D.H. & Levitt, P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 17, 103–111 (2007). source
Not checked in the free run.
- Premisecitation
In Alzheimer's disease, synaptic dysfunction is a preceding and contributing insult to eventual neuronal death.
“much evidence supports synaptic dysfunction as a preceding and contributing insult to eventual neuronal death7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789–791 (2002). source
Not checked in the free run.
- Premisecitation
Synapse and dendrite loss correlate more strongly with cognitive decline than neurofibrillary tangles or neuronal loss in Alzheimer's disease.
“Notably, synapse and dendrite loss demonstrate a stronger correlation to cognitive decline than do neurofibrillary tangles or neuronal loss18.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] DeKosky, S.T. & Scheff, S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457–464 (1990). source
Not checked in the free run.
- Premisecitation
Dystrophic neurites are associated with amyloid plaques in Alzheimer's disease brains.
“Dystrophic neurites are also associated with amyloid plaques in the brains of individuals with Alzheimer’s disease19,20.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] Walsh, D.M. & Selkoe, D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181–193 (2004). source
Not checked in the free run.
- cites [20] Knobloch, M. & Mansuy, I.M. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol. Neurobiol. 37, 73–82 (2008). source
Not checked in the free run.
- Premisecitation
Autism may be conceptualized as a disease of the synapse.
“Accumulating evidence from human neuropathological, genetic and model system studies suggests that autism may be conceptualized as a disease of the synapse8.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Toro, R. et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 26, 363–372 (2010). source
Not checked in the free run.
- Premisecitation
Synapse degeneration has a central role in Alzheimer's disease pathology.
“findings from neuropathological and molecular studies provide strong support for synapse degeneration as having a central role in Alzheimer’s disease pathology7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789–791 (2002). source
Not checked in the free run.
- Premisecitation
Dendritic spines undergo experience-dependent morphological changes in living animals.
“Spines undergo experience-dependent morphological changes in live animals2”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Holtmaat, A. & Svoboda, K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 10, 647–658 (2009). source
Not checked in the free run.
- Premisecitation
A rare copy number variant for ERBB4 has been identified in schizophrenia.
“Notably, a rare CNV for ERBB4 has been identified in schizophrenia46.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008). source
Not checked in the free run.
- Premisecitation
Rare variants in NLGN3, NLGN4, and NRXN1 have been genetically linked with autism.
“Rare variants in the genes for synaptic cell adhesion proteins neuroligin 3 and 4 (NLGN3, NLGN4) and their presynaptic ligand neurexin1 (NRXN1) have been genetically linked with autism28.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Südhof, T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903–911 (2008). source
Not checked in the free run.
- Premisecitation
Some studies report compensatory synaptic changes in Alzheimer's disease, such as increased size of remaining spines.
“The brain may possess an innate ability to forestall Alzheimer’s disease insults, as some studies note compensatory synaptic changes in Alzheimer’s disease, such as increased size in remaining spines22.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Fiala, J.C., Spacek, J. & Harris, K.M. Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res. Brain Res. Rev. 39, 29–54 (2002). source
Not checked in the free run.
- Premisecitation
Shank3 controls spine maintenance in the forebrain.
“Shank3 controls spine maintenance in forebrain33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Roussignol, G. et al. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 25, 3560–3570 (2005). source
Not checked in the free run.
- Premisecitation
Rare but highly penetrant copy number variants have been found in many genes encoding synaptic proteins in schizophrenia.
“In addition, rare but highly penetrant CNVs have been found in many genes encoding synaptic proteins46.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008). source
Not checked in the free run.
- Premisecitation
Many genes associated with ASD, schizophrenia, and Alzheimer's disease have defined roles in synapse regulation.
“Many of these genes have defined roles in synapse regulation25 (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] McClellan, J. & King, M.C. Genetic heterogeneity in human disease. Cell 141, 210–217 (2010). source
Not checked in the free run.
- Premisenone given
Postmortem expression studies reveal changes in molecules that regulate spine morphology in schizophrenia subjects.
“Postmortem expression studies revealed changes in molecules that regulate spine morphology in schizophrenia subjects.”
Quote in the paperSubstantial claim - Premisecitation
erbB4 knockdown reduces spine density and size in a cell-autonomous manner.
“Conversely, erbB4 knockdown reduces spine density and size in a cell-autonomous fashion49.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Li, B., Woo, R.S., Mei, L. & Malinow, R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54, 583–597 (2007). source
Not checked in the free run.
- Premisecitation
Layer 3 neurons undergo more substantial synaptic pruning during adolescence than layer 5/6 neurons in primates.
“This is interesting considering that layer 3 neurons undergo more substantial synaptic pruning during adolescence than layer 5/6 neurons in primates24.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Bourgeois, J.P., Goldman-Rakic, P.S. & Rakic, P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb. Cortex 4, 78–96 (1994). source
Not checked in the free run.
- Premisecitation
UBE3A encodes an E3 ubiquitin ligase whose maternal deficiency reduces dendritic spine density and length in cerebellar and hippocampal pyramidal neurons.
“UBE3A encodes an E3 ubiquitin ligase whose maternal deficiency reduces dendritic spine density and length in cerebellar and hippocampal pyramidal neurons45, suggesting a potential link between Angelman syndrome, autism and altered synaptic structure.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Dindot, S.V., Antalffy, B.A., Bhattacharjee, M.B. & Beaudet, A.L. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 17, 111–118 (2008). source
Not checked in the free run.
- Premisecitation
MeCP2, which is mutated in Rett syndrome, controls excitatory synapse function and spine morphology in an activity-dependent manner.
“MeCP2, a transcriptional regulator that is mutated in Rett syndrome, controls the function of excitatory synapses and spine morphology in an activity-dependent manner43.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255–269 (2006). source
Not checked in the free run.
- Interpretationreasoning
In ASD, increased spine density in layer 2 of frontal and parietal lobe but not layer 5 could indicate lamina-specific disruptions in synaptic formation and/or pruning.
“Similarly, in ASD the increase in spine density found in layer 2 of the frontal and parietal lobe, which was not evident in layer 5, could indicate lamina-specific disruptions in synaptic formation and/or pruning.”
Quote in the paperSubstantial claim - Premisecitation
Polymorphisms in NRG1 are associated with schizophrenia.
“Polymorphisms in NRG1 are associated with schizophrenia47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Mei, L. & Xiong, W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437–452 (2008). source
Not checked in the free run.
- Premisecitation
Autism-associated mutations in SHANK3 include frameshift, truncation, and missense mutations.
“Autism-associated mutations in SHANK3 (ref. 31) include a variety of frameshift, truncation and missense mutations”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Durand, C.M. et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25–27 (2007). source
Not checked in the free run.
- Premisecitation
Loss of TSC1 or TSC2 causes enlarged spines.
“and TSC1 or TSC2 loss causes enlarged spines39.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Tavazoie, S.F., Alvarez, V.A., Ridenour, D.A., Kwiatkowski, D.J. & Sabatini, B.L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8, 1727–1734 (2005). source
Not checked in the free run.
- Premisecitation
Loss of either ZDHHC8 or DGCR8 is sufficient to impair spine and dendrite morphology.
“Loss of either of two genes in this region (ZDHHC8 and DGCR8) was sufficient to impair spine and dendrite morphology50,51.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50] Stark, K.L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008). source
Not checked in the free run.
- cites [51] Mukai, J. et al. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 1302–1310 (2008). source
Not checked in the free run.
- Premisecitation
ASD and schizophrenia may be best described by a 'common disease, many rare mutations' model, with individually rare or private but highly penetrant mutations.
“It is becoming clear that disorders such as ASD and schizophrenia could be best described by a ‘common disease, many rare mutations’ model25, with mutations being individually rare or even ‘private’ (only accounting for a minority of cases), but highly penetrant.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] McClellan, J. & King, M.C. Genetic heterogeneity in human disease. Cell 141, 210–217 (2010). source
Not checked in the free run.
- Premisecitation
Rare structural variants of RAPGEF4, encoding the synaptic Rap guanine nucleotide exchange factor Epac2, have been identified in autistic individuals.
“Finally, rare structural variants of RAPGEF4, encoding the synaptically localized Rap guanine nucleotide exchange factor (GEF) Epac2, have been identified in autistic individuals35.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Bacchelli, E. et al. Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol. Psychiatry 8, 916–924 (2003). source
Not checked in the free run.
- Premisecitation
Primary hippocampal neurons from Df(16)A+/− mice show reduced spine density and sizes.
“Primary hippocampal neurons from mice engineered to carry the 1.3-Mb orthologous chromosomal region (Df(16)A+/−) showed reduced spine density and sizes51.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Mukai, J. et al. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 1302–1310 (2008). source
Not checked in the free run.
- Premisecitation
Maternal duplications of chromosome 15q11-q13 are associated with autism.
“Lastly, maternal duplications of chromosome 15q11–q13, a region that encompasses the Angelman syndrome gene UBE3A, are associated with autism44.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Cook, E.H. Jr. et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60, 928–934 (1997).
Not checked in the free run.
- Premisecitation
α-neurexin loss reduces dendrite length and total spine number in cortex.
“whereas α-neurexin loss reduces dendrite length and total spine number in cortex30.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Dudanova, I., Tabuchi, K., Rohlmann, A., Sudhof, T.C. & Missler, M. Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation. J. Comp. Neurol. 502, 261–274 (2007). source
Not checked in the free run.
- Premisecitation
PSD-95 protein levels are reduced in the schizophrenia cortex.
“Notably, PSD-95 protein levels are reduced in the schizophrenia cortex59.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Kristiansen, L.V., Beneyto, M., Haroutunian, V. & Meador-Woodruff, J.H. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry 11, 737–747, 705 (2006). source
Not checked in the free run.
- Premisecitation
KALRN mRNA expression is reduced in the dorsolateral prefrontal cortex of individuals with schizophrenia, irrespective of antipsychotic treatment.
“Notably, the expression of KALRN (kalirin) mRNA was reduced in the DLPFC of individuals with schizophrenia, irrespective of antipsychotic treatment56.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Hill, J.J., Hashimoto, T. & Lewis, D.A. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 11, 557–566 (2006). source
Not checked in the free run.
- Premisecitation
DISC1 interacts with several regulators of spine morphogenesis, most prominently the RacGEF kalirin-7.
“DISC1 is known to interact with several well-established regulators of spine morphogenesis, most prominently the RacGEF kalirin-7 (ref. 54).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327–332 (2010). source
Not checked in the free run.
- Premisecitation
Human APOE ε4 reduces dendritic length and branching in the mouse cortex and hippocampus.
“In another study, human APOE ε4 was found to reduce dendritic length and branching in the mouse cortex and hippocampus67.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Dumanis, S.B. et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J. Neurosci. 29, 15317–15322 (2009). source
Not checked in the free run.
- Premisecitation
Presynaptic proteins such as synaptophysin are reduced in individuals with mild cognitive impairment or Alzheimer's disease.
“Presynaptic proteins such as synaptophysin are reduced in individuals with MCI or Alzheimer’s disease7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789–791 (2002). source
Not checked in the free run.
- Premisecitation
mRNA and protein levels of kalirin-7 are substantially diminished in the hippocampus of individuals with Alzheimer's disease.
“Notably, mRNA and protein levels of kalirin-7, a key regulator of spine morphogenesis and an upstream activator of PAK in spines, were found to be substantially diminished in the hippocampus of individuals with Alzheimer’s disease71,72, suggesting a role for the kalirin-7–Rac1–PAK pathway in Alzheimer’s disease–associated spine pathology.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [71] Xie, Z. et al. Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 56, 640–656 (2007). source
Not checked in the free run.
- cites [72] Youn, H. et al. Kalirin is under-expressed in Alzheimer's disease hippocampus. J. Alzheimers Dis. 11, 385–397 (2007). source
Not checked in the free run.
- Premisecitation
Calcineurin over-activation has been reported in individuals with Alzheimer's disease and in animal models.
“however, calcineurin over-activation has been reported in individuals with Alzheimer’s disease and animal models73.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Norris, C.M. et al. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J. Neurosci. 25, 4649–4658 (2005). source
Not checked in the free run.
- Premisecitation
Kalirin-7, through activation of its downstream effector Rac1, directly regulates the effects of DISC1 on spine morphology.
“Recently, kalirin-7, via activation of its downstream effector Rac1, was found to directly regulate the effects of DISC1 on spine morphology54.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327–332 (2010). source
Not checked in the free run.
- Premisecitation
Aβ oligomer-induced spine loss and dendritic dystrophies can be prevented by calcineurin inhibition.
“Notably, Aβ oligomer–induced spine loss and dendritic dystrophies can be prevented by calcineurin inhibition76.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] Wu, H.Y. et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J. Neurosci. 30, 2636–2649 (2010). source
Not checked in the free run.
- Premisecitation
Loss of kalirin strongly correlates with spine loss in layer 3 prefrontal cortex neurons.
“Loss of kalirin strongly correlates with spine loss in layer 3 prefrontal cortex neurons56.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Hill, J.J., Hashimoto, T. & Lewis, D.A. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 11, 557–566 (2006). source
Not checked in the free run.
- Premisecitation
There is an inverse correlation between APOE ε4 dose and dentate gyrus spine density in human brain.
“The authors also found an inverse correlation between APOE ε4 dose and dentate gyrus spine density in human brain.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Ji, Y. et al. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122, 305–315 (2003). source
Not checked in the free run.
- Premisecitation
Individuals with Alzheimer's disease demonstrate altered expression of many synaptic proteins.
“Individuals with Alzheimer’s disease demonstrate altered expression of many synaptic proteins21.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Arendt, T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167–179 (2009). source
Not checked in the free run.
- Premisecitation
Expression of APOE ε2 in a mouse model of Alzheimer's disease can restore spine density to control levels.
“It has also been reported that expression of APOE ε2 in a mouse model of Alzheimer’s disease can restore spine density to control levels68.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Lanz, T.A., Carter, D.B. & Merchant, K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 13, 246–253 (2003). source
Not checked in the free run.
- Premisecitation
Polymorphisms and frame shift mutations of DISC1 have been linked to schizophrenia in other lineages.
“Polymorphisms and frame shift mutations of DISC1 have been linked to schizophrenia in other lineages53.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Schumacher, J. et al. The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. Hum. Mol. Genet. 18, 2719–2727 (2009). source
Not checked in the free run.
- Premisecitation
Long-term DISC1 knockdown in cortical neurons reduces spine area.
“Long-term DISC1 knockdown in cortical neurons reduces spine area54.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327–332 (2010). source
Not checked in the free run.
- Interpretationcitation
In Alzheimer's disease, Aβ oligomers promote synaptic degeneration by acting on spines to create an imbalance of synaptic plasticity mechanisms.
“Many of the signaling molecules identified as having a potential role in Alzheimer’s disease pathogenesis lend support to the emerging hypothesis that, in Alzheimer’s disease, Aβ oligomers promote synaptic degeneration by acting on spines to create an imbalance of synaptic plasticity mechanisms62,77 (Fig. 4).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [62] Selkoe, D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106–113 (2008). source
Not checked in the free run.
- cites [77] Hsieh, H. et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831–843 (2006). source
Not checked in the free run.
- Premisecitation
APOE is widely accepted as the most important risk factor for late-onset Alzheimer's disease.
“Although hundreds of genes have been proposed as LOAD risk factors, the gene encoding apolipoprotein E (APOE) is widely accepted as the most important risk factor65.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Sleegers, K. et al. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet. 26, 84–93 (2010). source
Not checked in the free run.
- Premisecitation
Long-term depression induced by Aβ oligomers in hippocampal CA1 requires calcineurin activity.
“Long-term depression induced by Aβ oligomers in hippocampal CA1 requires calcineurin activity, evidence that aberrant molecular changes in Alzheimer’s disease also give rise to functional deficits74.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Li, S. et al. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788–801 (2009). source
Not checked in the free run.
- Interpretationreasoning
Over-activation of an NMDAR-calcineurin-GSK-3β pathway may indicate a mechanism by which synapses degenerate in Alzheimer's disease.
“Thus, over-activation of a NMDAR–calcineurin–GSK-3β pathway may indicate a mechanism by which synapses degenerate in Alzheimer’s disease.”
Quote in the paperSubstantial claim - Premisecitation
ErbB4 and DISC1 interact with PSD-95 in spines.
“ErbB4 and DISC1 interact with PSD-95 in spines54,58.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [54] Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327–332 (2010). source
Not checked in the free run.
- cites [58] Garcia, R.A., Vasudevan, K. & Buonanno, A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc. Natl. Acad. Sci. USA 97, 3596–3601 (2000). source
Not checked in the free run.
- Premisecitation
Mice expressing human APOE ε4 display reduced spine density in the dentate gyrus compared with wild-type mice and mice expressing human APOE ε3.
“Mice expressing human APOE ε4 display reduced spine density in the dentate gyrus when compared with wild-type mice and mice expressing human APOE ε3 (ref. 66).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Ji, Y. et al. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122, 305–315 (2003). source
Not checked in the free run.
- Premisecitation
DISC1 mRNA levels appear unaffected in individuals with schizophrenia.
“Although DISC1 mRNA levels seem unaffected in individuals with schizophrenia55”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Lipska, B.K. et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet. 15, 1245–1258 (2006). source
Not checked in the free run.
- Premisecitation
Several postsynaptic signaling molecules are affected in Alzheimer's disease.
“and several postsynaptic signaling molecules are also affected in Alzheimer’s disease.”
Quote in the paperNot a substantial claim - Premisecitation
In the hippocampus of individuals with Alzheimer's disease and in animal models, PAK activation is markedly reduced and mislocalized.
“In the hippocampus of individuals with Alzheimer’s disease and in animal models of Alzheimer’s disease, PAK activation is markedly reduced and mislocalized69.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Zhao, L. et al. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 9, 234–242 (2006). source
Not checked in the free run.
- Interpretationcitation
DISC1 mutations in mice affect spine density in ways that depend on brain region and developmental timing.
“The effects of DISC1 mutations in mice on spine density reflect brain region and developmentally influenced effects.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [90] Kvajo, M. et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. USA 105, 7076–7081 (2008). source
Not checked in the free run.
- cites [91] Ayhan, Y. et al. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry. published online, doi:10.1038/mp.2009.144 (5 January 2010). source
Not checked in the free run.
- Interpretationreasoning
The reversal of spine pathologies accompanying behavioral recovery in these rescue strategies underscores the importance of structural perturbations in the pathogenesis of ASDs and comorbid disorders.
“That behavioral recovery in each of these rescue strategies was paralleled by reversal of spine pathologies underscores the importance of these structural perturbations in the pathogenesis of ASDs and comorbid disorders and the potential for the use of animal models in the development of therapeutics.”
Quote in the paperSubstantial claim - Premisecitation
CNS-specific loss of erbB2 and erbB4 in mice reduces spine density in the hippocampus and cortex.
“Mice lacking erbB2 and erbB4 in the CNS show reduced spine density in both the hippocampus and cortex48.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48] Barros, C.S. et al. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl. Acad. Sci. USA 106, 4507–4512 (2009). source
Not checked in the free run.
- Premisecitation
Prenatal mutant DISC1 expression raised spine density in cortical pyramidal neurons.
“Spine density in cortical pyramidal neurons was increased by prenatal expression of mutant DISC1, whereas combined prenatal and postnatal expression increased spine density in hippocampal granule cells91.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] Ayhan, Y. et al. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry. published online, doi:10.1038/mp.2009.144 (5 January 2010). source
Not checked in the free run.
- Premisecitation
NRG1 type III-deficient mice have reduced spine density in hippocampal neurons.
“Mice deficient in NRG1 type III show reductions in spine density in hippocampal neurons89.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Chen, Y.J. et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci. 28, 6872–6883 (2008). source
Not checked in the free run.
- Interpretationcitation
Soluble Aβ oligomers are responsible for initiating at least part of Alzheimer's disease pathology.
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [68] Lanz, T.A., Carter, D.B. & Merchant, K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 13, 246–253 (2003). source
Not checked in the free run.
- cites [95] Jacobsen, J.S. et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer′s disease. Proc. Natl. Acad. Sci. USA 103, 5161–5166 (2006). source
Not checked in the free run.
- Premisenone given
Synaptic structural differences that might underlie phenotypes in NLGN3-R451C mice have not been explored.
“Notably, the synaptic structural differences that might underlie these phenotypes, such as whether a compensatory increase in excitatory synapse number occurs in these mice, have not been explored in either of these transgenic models.”
Quote in the paperNot a substantial claim - Premisecitation
Prenatal plus postnatal mutant DISC1 expression raised spine density in hippocampal granule cells.
“Spine density in cortical pyramidal neurons was increased by prenatal expression of mutant DISC1, whereas combined prenatal and postnatal expression increased spine density in hippocampal granule cells91.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] Ayhan, Y. et al. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry. published online, doi:10.1038/mp.2009.144 (5 January 2010). source
Not checked in the free run.
- Premisecitation
The Angelman syndrome mouse lacking maternal UBE3A has abnormal spine density on pyramidal neurons in the hippocampus and cortex.
“The Angelman syndrome mouse, which lacks the maternal UBE3A gene, displays motor deficits, impaired context-dependent learning, impaired plasticity and altered spine density on hippocampal and cortical pyramidal neurons45,85.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [45] Dindot, S.V., Antalffy, B.A., Bhattacharjee, M.B. & Beaudet, A.L. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 17, 111–118 (2008). source
Not checked in the free run.
- cites [85] Yashiro, K. et al. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 12, 777–783 (2009). source
Not checked in the free run.
- Premisecitation
Mouse models of ASD with deficits in up to three core behavioral domains approximate ASDs in tasks such as social approach, ultrasonic vocalizations, and repetitive motor behaviors.
“Mouse models of ASD, with deficits in up to three core behavioral domains, have begun to approximate ASDs in newly developed behavioral tasks, such as social approach, ultrasonic vocalizations and measurements of repetitive motor behaviors79.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Silverman, J.L., Yang, M., Lord, C. & Crawley, J.N. Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490–502 (2010). source
Not checked in the free run.
- Interpretationreasoning
Animal models that model schizophrenia-related behavioral phenotypes and forebrain spine loss support the contribution of spine loss to schizophrenia.
“Support for the contribution of spine loss to schizophrenia comes from animal models that are able to model schizophrenia-related behavioral phenotypes as well as model the forebrain spine loss in the disease.”
Quote in the paperSubstantial claim - Premisecitation
In these rescue strategies, behavioral recovery was paralleled by reversal of spine pathologies.
“That behavioral recovery in each of these rescue strategies was paralleled by reversal of spine pathologies underscores the importance of these structural perturbations in the pathogenesis of ASDs and comorbid disorders and the potential for the use of animal models in the development of therapeutics.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [86] Zhou, J. et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J. Neurosci. 29, 1773–1783 (2009). source
Not checked in the free run.
- cites ref. 87
Not checked in the free run.
- cites ref. 88
Not checked in the free run.
- Premisecitation
Both these mouse lines show spine morphological deficits together with schizophrenia-related behavioral phenotypes.
“In both of these mouse lines, spine morphological deficits co-occur with schizophrenia-related behavioral phenotypes.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [89] Chen, Y.J. et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci. 28, 6872–6883 (2008). source
Not checked in the free run.
- cites [48] Barros, C.S. et al. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl. Acad. Sci. USA 106, 4507–4512 (2009). source
Not checked in the free run.
- Interpretationreasoning
In these animals, the timing of spine loss is tightly linked to the timing of behavioral impairment.
“This is interesting given the onset of schizophrenia symptoms in adolescence in humans and points to a tight association between the onset of spine loss and the onset of behavioral impairments in these animals.”
Quote in the paperSubstantial claim - Premisecitation
Kalrn knockout mice have severely reduced spine density and dendrite complexity in the frontal cortex.
“Notably, Kalrn−/− mice show severe reductions in spine density and dendrite complexity in the frontal cortex, as well as schizophrenia-related impairments in working memory, sociability and prepulse inhibition92,93.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [92] Cahill, M.E. et al. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl. Acad. Sci. USA 106, 13058–13063 (2009). source
Not checked in the free run.
- cites [93] Xie, Z., Cahill, M.E. & Penzes, P. Kalirin loss results in cortical morphological alterations. Mol. Cell. Neurosci. 43, 81–89 (2010). source
Not checked in the free run.
- Premisecitation
The synapse loss in MeCP2-deficient mice mirrors the synapse loss seen in humans with Rett syndrome.
“Rett syndrome can be effectively modeled using mice deficient in MeCP2, which exhibit decreases in the number of functional, excitatory synapses in these mice83, mirroring synapse loss seen in humans.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Chao, H.T., Zoghbi, H.Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58–65 (2007). source
Not checked in the free run.
- Premisecitation
DGCR8-deficient mice have smaller spines.
“Mice deficient in individual genes in this region (ZDHHC8 and DGCR8) show simplified dendritic trees and reduced spine density51 or smaller spines50, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Stark, K.L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008). source
Not checked in the free run.
- Premisecitation
Fmr1 knockout mice recapitulate the immature spine morphologies observed in human fragile X syndrome brains.
“Modeling fragile X syndrome using Fmr1 knockout mice has recapitulated the immature spine morphologies observed in the brains of humans with fragile X syndrome84.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [84] Irwin, S.A. et al. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am. J. Med. Genet. 111, 140–146 (2002). source
Not checked in the free run.
- Premisecitation
A mouse model of a disease-associated chromosomal translocation has fewer spines on dentate gyrus granule cells.
“Namely, spine numbers in dentate gyrus granule cells are reduced in a mouse model of disease-associated chromosomal translocation90.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [90] Kvajo, M. et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. USA 105, 7076–7081 (2008). source
Not checked in the free run.
- Premisecitation
Mice lacking MeCP2 have fewer functional excitatory synapses.
“Rett syndrome can be effectively modeled using mice deficient in MeCP2, which exhibit decreases in the number of functional, excitatory synapses in these mice83, mirroring synapse loss seen in humans.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Chao, H.T., Zoghbi, H.Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58–65 (2007). source
Not checked in the free run.
- Interpretationreasoning
Spine deficits may matter more for certain cognitive symptoms than others, such as working memory deficits rather than hallucinations in schizophrenia.
“However, as spine modifications are associated with cognitive function, spine deficits may be more relevant for some cognitive symptoms or endophenotypes than others (for example, in schizophrenia, working memory deficits, but not hallucinations).”
Quote in the paperSubstantial claim - Interpretationreasoning
Dendritic spines could be a shared substrate for many neuropsychiatric disorders, especially those with cognitive deficits.
“Dendritic spines may serve as a common substrate for many neuropsychiatric disorders, particularly those that involve cognitive deficits.”
Quote in the paperSubstantial claim - Interpretationcitation
Alzheimer's disease pathology may destabilize widespread neuronal networks.
“Similarly, individuals with Alzheimer’s disease experience increased incidence of seizures compared with non-demented controls, suggesting that Alzheimer’s disease pathology may be involved in destabilizing broad neuronal networks100.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Palop, J.J. & Mucke, L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13, 812–818 (2010). source
Not checked in the free run.
- Premisecitation
People with Alzheimer's disease have more seizures than non-demented controls.
“Similarly, individuals with Alzheimer’s disease experience increased incidence of seizures compared with non-demented controls, suggesting that Alzheimer’s disease pathology may be involved in destabilizing broad neuronal networks100.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Palop, J.J. & Mucke, L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13, 812–818 (2010). source
Not checked in the free run.
- Premisecitation
Some evidence indicates that pharmacological treatment can reverse structural and functional changes in Alzheimer's disease.
“However, at least some evidence suggests structural and functional alterations may be reversible pharmacologically, opening new therapeutic directions in Alzheimer’s disease98.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [98] Smith, D.L., Pozueta, J., Gong, B., Arancio, O. & Shelanski, M. Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc. Natl. Acad. Sci. USA 106, 16877–16882 (2009). source
Not checked in the free run.
- Interpretationcitation
The frequent co-occurrence of epilepsy and ASD may reflect the excitatory/inhibitory imbalance seen in some ASD mouse models.
“For example, the coincidence of epilepsy with ASD in a large percentage of individuals with ASD99 may be an expression of the excitatory/inhibitory synaptic imbalance observed in several ASD mouse models.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] Spence, S.J. & Schneider, M.T. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr. Res. 65, 599–606 (2009). source
Not checked in the free run.
- Interpretationreasoning
Loss of synapses can cause cognitive decline.
“Notably, cognitive impairments arise in these mice at the time when spines become depleted, suggesting that synapse loss can drive cognitive decline.”
Quote in the paperSubstantial claim - Premisecitation
Cognitive deficits in Tg2576 mice appear when spines are depleted.
“Notably, cognitive impairments arise in these mice at the time when spines become depleted, suggesting that synapse loss can drive cognitive decline.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Jacobsen, J.S. et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer′s disease. Proc. Natl. Acad. Sci. USA 103, 5161–5166 (2006). source
Not checked in the free run.
- Interpretationreasoning
Single-transgene mouse models may not capture the full human presentation of complex diseases like ASD, schizophrenia, and Alzheimer's disease.
“However, in modeling complex diseases, such as ASD, schizophrenia and Alzheimer’s disease, mouse models with a single transgene may fall short of the entire presentation of the disease as seen in humans.”
Quote in the paperSubstantial claim - Interpretationreasoning
Animal models of Alzheimer's disease support the idea that synaptic degeneration is a major part of the pathology causing memory impairment.
“Such Alzheimer’s disease animal models support the concept that synaptic degeneration represents a principal component of Alzheimer’s disease pathology that leads to memory impairment.”
Quote in the paperSubstantial claim - Interpretationreasoning
Spine-regulating molecular networks offer a framework for how many rare genetic changes interact to disrupt synaptic function, circuits, and behavior in disease-specific ways.
“The molecular networks that control spines provide a framework for understanding how a large number of rare genetic perturbations can interact to disrupt synaptic function, neuronal circuit organization and behavioral output in a disease-specific manner.”
Quote in the paperSubstantial claim
- May combine two claims. 67
- Classified as probably not a substantial claim. 9
May combine two claims.
PremisecitationIn post-mortem ASD brain tissue, spine density is increased on apical dendrites of pyramidal neurons in cortical layer 2 of frontal, temporal, and parietal lobes, and in layer 5 only in the temporal lobe.
“This recent evidence from Golgi-impregnated post-mortem ASD human brain tissue revealed an increase in spine density on apical dendrites of pyramidal neurons from cortical layer 2 in frontal, temporal and parietal lobes and layer 5 only in the temporal lobe4.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Hutsler, J.J. & Zhang, H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309, 83–94 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationThe dorsolateral prefrontal cortex shows severe dysfunction in schizophrenia, with reduced activity during cognitive tasks.
“The dorsolateral prefrontal cortex (DLPFC) shows severe dysfunction in schizophrenia, as affected individuals show reduced activity of this region during cognitive tasks13.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Tan, H.Y., Callicott, J.H. & Weinberger, D.R. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb. Cortex 17, i171–i181 (2007). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBecause symptoms of ASD, schizophrenia, and Alzheimer's disease appear at different life stages, dysregulation of synaptic structure and function may coincide with distinct cognitive and behavioral deficits depending on when it occurs.
“Notably, the symptoms of each of these disorders manifest at distinct stages of life, suggesting that dysregulation of synaptic structure and function can coincide with unique deficits in cognition and behavior depending on when the disruptions occur across the lifespan (Fig. 1).”
Quote in the paperSubstantial claim- Rests on an assumption: Symptoms of ASD, schizophrenia, and Alzheimer's disease manifest at distinct stages of life.
May combine two claims.
PremisecitationSynapse loss occurs in mild cognitive impairment and is greater in Alzheimer's disease, indicating that it begins early and worsens with disease progression.
“Detailed analysis of postmortem tissue has revealed synapse loss in mild cognitive impairment (MCI), but an even greater loss in Alzheimer’s disease, indicating that synapse loss occurs early in the progression of Alzheimer’s disease and worsens as the disease advances21.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] Arendt, T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167–179 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationGray matter loss is a defining neuropathological feature of schizophrenia and is accelerated during periadolescence.
“One of the defining neuropathological features of schizophrenia is gray matter loss, which is accelerated during periadolescence12.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Gogtay, N. Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia. Schizophr. Bull. 34, 30–36 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationSpine enlargement is associated with long-term potentiation, while long-term depression is associated with spine shrinkage.
“for example, spine enlargement parallels long-term potentiation, whereas long-term depression is associated with spine shrinkage1.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Kasai, H., Fukuda, M., Watanabe, S., Hayashi-Takagi, A. & Noguchi, J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 33, 121–129 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationThe fragile X brain shows elevated spine density, thought to result from pruning deficits, with elongated and tortuous spine morphologies.
“Similar to ‘pure’ autism, the fragile X brain is characterized by elevated spine density, which is thought to result from pruning deficits, with elongated, tortuous spine morphologies11, indicative of altered function.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Irwin, S.A. et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am. J. Med. Genet. 98, 161–167 (2001). source
Not checked in the free run.
May combine two claims.
PremisecitationSchizophrenia is associated with reduced hippocampal volume and reduced spine density on subicular and CA3 dendrites.
“Several studies have shown reductions in hippocampal volume and reduced spine density on subicular and CA3 dendrites in schizophrenia16,17.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] Steen, R.G., Mull, C., McClure, R., Hamer, R.M. & Lieberman, J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188, 510–518 (2006). source
Not checked in the free run.
- cites [17] Kolomeets, N.S., Orlovskaya, D.D., Rachmanova, V.I. & Uranova, N.A. Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse 57, 47–55 (2005). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningNLGN3, NRXN1, Epac2, and the Shank proteins form a synaptic regulatory pathway whose disruption could produce ASD-like synapse pathology.
“Thus, NLGN3, NRXN1, Epac2 and the Shank proteins constitute members of a synaptic regulatory pathway, disruption of which could confer ASD-like synapse pathology.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationRare mutations and copy number variants in genes encoding synaptic proteins have been identified in autistic individuals, supporting a role for synaptic dysfunction in ASD etiology.
“Notably, multiple reports have identified rare mutations and CNVs in genes encoding synaptic proteins in autistic individuals, supporting the hypothesis that synaptic dysfunction may be important in the etiology of ASDs8.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Toro, R. et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 26, 363–372 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationZDHHC8 palmitoylates PSD-95; its loss reduces spine density and simplifies dendrites, and replacement rescues spine and dendrite deficiency in Df(16)A+/− neurons.
“ZDHHC8 is a palmitoyl transferase that palmitoylates the postsynaptic density scaffolding molecule PSD-95; ZDHHC8 loss results in reduced spine density and simpler dendrites and its replacement into Df(16)A+/− neurons rescued spine and dendrite deficiency51.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Mukai, J. et al. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 1302–1310 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningIn schizophrenia, it is likely that spine formation and stability are reduced or spine pruning is accelerated.
“Although postmortem studies cannot identify the root cause of spine loss, it is likely that spine formation and stability are reduced or spine pruning is accelerated in schizophrenia (Fig. 1).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNeuregulins are trophic factors that exist in membrane-bound and soluble forms, and ErbB receptors are postsynaptic receptor tyrosine kinases activated by neuregulin binding.
“Neuregulins are trophic factors that exist in both membrane-bound and soluble form. ErbB receptors are postsynaptic receptor tyrosine kinases and are activated on neuregulin binding47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Mei, L. & Xiong, W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437–452 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationPTEN deficiency results in dendritic hypertrophy and elevated spine density.
“PTEN deficiency results in dendritic hypertrophy and elevated spine density41”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Kwon, C.H. et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377–388 (2006). source
Not checked in the free run.
May combine two claims.
PremisecitationMutations in TSC1, TSC2, or PTEN are frequently diagnosed with autism, and each of these proteins regulates synaptic structure.
“Individuals with mutations of tuberous sclerosis proteins 1 and 2 (TSC1, TSC2) or the phosphatase and tensin homolog (PTEN) gene, which causes macroencephaly, are frequently diagnosed with autism38 and each of these proteins regulates synaptic structure39,40.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [38] Butler, M.G. et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 42, 318–321 (2005). source
Not checked in the free run.
- cites [39] Tavazoie, S.F., Alvarez, V.A., Ridenour, D.A., Kwiatkowski, D.J. & Sabatini, B.L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8, 1727–1734 (2005). source
Not checked in the free run.
- cites [40] Fraser, M.M., Bayazitov, I.T., Zakharenko, S.S. & Baker, S.J. Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 151, 476–488 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningNeuropathological evidence points toward synapse and dendritic spine loss in schizophrenia and Alzheimer's disease, whereas ASDs appear characterized by increased spine numbers.
“In summary, neuropathological evidence points toward synapse and dendritic spine loss in schizophrenia and Alzheimer’s disease, whereas ASDs seem characterized by increased spine numbers.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNLGN3 or NLGN4 increase excitatory synapse number in hippocampal neurons, and the NLGN3 Arg451Cys variant prevents this induction.
“Data gleaned from cell biological studies have shown that NLGN3 or NLGN4 increase excitatory synapse number in hippocampal neurons and the NLGN3 Arg451Cys variant prevents this induction of synapse formation29”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Chih, B., Afridi, S.K., Clark, L. & Scheiffele, P. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum. Mol. Genet. 13, 1471–1477 (2004). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe initial link of DISC1 to schizophrenia was identified in a Scottish pedigree with a disruption of the DISC1 open reading frame.
“The initial link of the disrupted in schizophrenia 1 (DISC1) gene to schizophrenia was identified in a Scottish pedigree with a disruption of the DISC1 open reading frame52.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] St. Clair, D. et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13–16 (1990). source
Not checked in the free run.
May combine two claims.
PremisecitationDe novo copy number variants and an inherited point mutation in SHANK2 have been identified in patients with ASD and mental retardation.
“more recently, de novo CNVs and inherited point mutation have been identified in the SHANK2 gene in patients with ASD and mental retardation32.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Berkel, S. et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42, 489–491 (2010). source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningNeuropathological studies are performed at advanced disease stages, reflect an endpoint, and cannot distinguish cause, consequence, compensation, or confound.
“As these neuropathological studies are performed in an advanced stage of the disease, they reflect an endpoint of the disease process and do not distinguish between cause, consequence, compensation or confound.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationErbB4 overexpression increases spine density, area, and excitatory synaptic transmission.
“ErbB4 overexpression increases spine density, area and excitatory synaptic transmission49.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Li, B., Woo, R.S., Mei, L. & Malinow, R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54, 583–597 (2007). source
Not checked in the free run.
May combine two claims.
PremisecitationEpac2 missense mutations increase dendritic spine number and area.
“Epac2 missense mutations increase dendritic spine number (Epac2-T809S) and area (Epac2-V646F)36.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Woolfrey, K.M. et al. Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines. Nat. Neurosci. 12, 1275–1284 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationShank3 may complex with and signal downstream of NLGNs.
“and Shank3 may complex with and signal downstream of NLGNs37.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] Bourgeron, T. A synaptic trek to autism. Curr. Opin. Neurobiol. 19, 231–234 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationIn schizophrenia, spine loss occurs in layer 3 of the dorsolateral prefrontal cortex but not in layers 5 and 6.
“Notably, in schizophrenia, loss of spines occurs in layer 3 of the DLPFC5, but not in layers 5 and 6 (ref. 23).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5] Glantz, L.A. & Lewis, D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65–73 (2000). source
Not checked in the free run.
- cites [23] Kolluri, N., Sun, Z., Sampson, A.R. & Lewis, D.A. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 162, 1200–1202 (2005). source
Not checked in the free run.
May combine two claims.
PremisecitationFragile X syndrome results from transcriptional silencing of FMR1, which causes upregulated global dendritic translation rates that may contribute to elevated spine density.
“Fragile X syndrome results from transcriptional silencing of the FMR1 gene, which in turn causes an upregulation in global dendritic translation rates that may contribute to the elevated spine density observed in the brains of affected individuals42.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Bagni, C. & Greenough, W.T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6, 376–387 (2005). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe 22q11.2 microdeletion syndrome is the most common copy number variant associated with schizophrenia, accounting for 1-2% of cases.
“The 22q11.2 microdeletion syndrome is the most common CNV associated with schizophrenia, accounting for 1–2% of cases50.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Stark, K.L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationNLGN3 complexes with Epac2 and enhances its signaling activity.
“Notably, NLGN3 also complexes with Epac2 and enhances its signaling activity36”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Woolfrey, K.M. et al. Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines. Nat. Neurosci. 12, 1275–1284 (2009). source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenPostmortem human tissue studies have caveats including postmortem interval, symptomatic heterogeneity, and patient medical history.
“Several caveats must accompany studies of postmortem human tissue, such as postmortem interval, symptomatic heterogeneity and patient medical history.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDgcr8 is involved in miRNA processing, and its loss results in smaller spines and simpler dendrites.
“Dgcr8 is involved in miRNA processing and its loss results in smaller spines and simpler dendrites50.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Stark, K.L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationcitationSynapse loss in Alzheimer's disease often exceeds what neuronal death would predict, indicating that synaptic dysgenesis is a prominent pathology rather than a byproduct and contributes to cognitive decline.
“Furthermore, synapse loss often appears greater than what would be expected from neuronal death, underscoring synaptic dysgenesis as a prominent pathology of Alzheimer’s disease, rather than a byproduct, and a driving factor in cognitive decline19.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Walsh, D.M. & Selkoe, D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181–193 (2004). source
Not checked in the free run.
May combine two claims.
PremisecitationNRG1 and erbB4 regulate spine structure and function, and long-term NRG1 treatment increases pyramidal neuronal spine density and the proportion of mature spine phenotypes.
“NRG1 and erbB4 regulate spine structure and function; long-term NRG1 treatment increases pyramidal neuronal spine density and the preponderance of spines with mature phenotypes48.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Barros, C.S. et al. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl. Acad. Sci. USA 106, 4507–4512 (2009). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationShank2 is implicated in activity-dependent spine remodeling.
“whereas Shank2 has been implicated in activity-dependent spine remodeling34.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Steiner, P. et al. Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. Neuron 60, 788–802 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationSeveral missense mutations in KALRN have been identified in schizophrenia, occur in conserved regions, and are predicted to have functional consequences.
“Recently, several missense mutations in the KALRN gene were identified in schizophrenia. These mutations occurred in evolutionary conserved gene regions and are predicted to have functional consequences57.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Kushima, I. et al. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Schizophr. Bull. published online, doi:10.1093/schbul/sbq118 (1 November 2010). source
Not checked in the free run.
May combine two claims.
PremisecitationExpression of DISC1-interacting proteins is reduced in individuals carrying high-risk DISC1 SNPs, suggesting that DISC1 function might be affected in schizophrenia.
“the expression of DISC1-interacting proteins was reduced in individuals carrying high-risk DISC1 SNPs55, suggesting that DISC1 function might be affected in schizophrenia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Lipska, B.K. et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet. 15, 1245–1258 (2006). source
Not checked in the free run.
May combine two claims.
Interpretationnone givenGenetic data suggest Aβ is vital for Alzheimer's disease pathogenesis, and molecular studies indicate Aβ acts on synapses to mediate toxic effects.
“An abundance of genetic data suggests that Aβ is vital for Alzheimer’s disease pathogenesis and molecular studies indicate that Aβ acts on synapses to mediate its toxic effects.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe APOE ε4 allele is associated with greater risk of Alzheimer's disease, whereas APOE ε2 is considered neuroprotective.
“Specifically, the ε4 (APOE ε4) allele is associated with greater risk of developing Alzheimer’s disease, whereas APOE ε2 is considered to be neuroprotective.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDrebrin is reduced in the brains of individuals with Alzheimer's disease and in transgenic animal models.
“Drebrin, a postsynaptic protein that binds and stabilizes actin in spines, is reduced in the brains of individuals with Alzheimer’s disease and in transgenic animal models of the disease20.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Knobloch, M. & Mansuy, I.M. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol. Neurobiol. 37, 73–82 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationPICALM, a GWAS susceptibility gene, is associated with inducing dendritic dystrophy and disrupting vesicle transport when underexpressed in embryonic hippocampal neurons.
“Notably, PICALM, another susceptibility gene identified by GWAS, has been associated with inducing dendritic dystrophy and disrupting vesicle transport when underexpressed in embryonic hippocampal neurons65.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Sleegers, K. et al. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet. 26, 84–93 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationAβ oligomers target spines, induce spine dysgenesis, and reduce spine density.
“Furthermore, Aβ oligomers have been clearly shown to target spines, induce spine dysgenesis, and reduce spine density63,64.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [63] Lacor, P.N. et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27, 796–807 (2007). source
Not checked in the free run.
- cites [64] Shankar, G.M. et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor–dependent signaling pathway. J. Neurosci. 27, 2866–2875 (2007). source
Not checked in the free run.
May combine two claims.
PremisecitationCofilin and drebrin are actin-binding proteins with opposite effects on actin dynamics, and both are affected in Alzheimer's disease.
“Cofilin and drebrin are actin-binding proteins that exert opposite effects on actin dynamics, but both are affected in Alzheimer’s disease.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationActive cofilin causes actin destabilization, and much evidence supports a role for cofilin in neurodegeneration, including Alzheimer's disease.
“Active cofilin causes actin destabilization and much evidence supports a role for cofilin in neurodegeneration, including Alzheimer’s disease20.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Knobloch, M. & Mansuy, I.M. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol. Neurobiol. 37, 73–82 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationFamilial Alzheimer's disease has autosomal dominant inheritance and early onset and is associated with mutations in APP, PSEN1, and PSEN2, which are critical for Aβ production.
“Familial Alzheimer’s disease, which has an autosomal dominant form of inheritance and early onset, has been associated with mutations in APP, PSEN1 and PSEN2, three genes that are critical for beta amyloid (Aβ) production61.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Bertram, L. & Tanzi, R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 9, 768–778 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationA recent independent GWAS reaffirmed APOE as the primary Alzheimer's disease genetic risk factor and identified new late-onset Alzheimer's disease susceptibility genes.
“A recent independent GWAS, in addition to reaffirming APOE as the primary Alzheimer’s disease genetic risk factor, identified new LOAD susceptibility genes65.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Sleegers, K. et al. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet. 26, 84–93 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationPharmacological inhibition of PAK in mice is sufficient to cause memory impairment, cofilin pathology, and drebrin loss.
“Furthermore, pharmacological inhibition of PAK in mice was sufficient to cause memory impairment, cofilin pathology and drebrin loss.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenCLU has many similarities to ApoE, including the ability to bind Aβ.
“One example is the gene encoding for clusterin (CLU), also known as ApoJ, which has many similarities to ApoE, including the ability to bind Aβ.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMutations in familial Alzheimer's disease increase Aβ production, and cellular studies provide compelling evidence that soluble Aβ oligomers disrupt synaptic signaling.
“Mutations found in familial Alzheimer’s disease are well known to increase Aβ production and cellular studies provide compelling evidence that soluble Aβ oligomers disrupt synaptic signaling (reviewed in ref. 62).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Selkoe, D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106–113 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationcitationLoss of scaffolding proteins in spines could alter glutamatergic receptor signaling, which is theorized to contribute to schizophrenia etiology.
“A loss of scaffolding proteins in spines could alter glutamatergic receptor signaling, disruption of which is theorized to contribute to the etiology of schizophrenia60.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Coyle, J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 26, 365–384 (2006). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe major genetic risk factor for late-onset Alzheimer's disease affects dendrite and spine morphology, but the underlying mechanisms remain unknown.
“It is fascinating that the major genetic risk factor for LOAD affects dendrite and spine morphology, but the underlying mechanisms remain unknown and require further investigation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPAK is a critical regulator of actin assembly in spines and a downstream effector of Rac.
“A critical regulator of actin assembly in spines is p21-activated kinase (PAK), a downstream effector molecule of Rac69,70.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [69] Zhao, L. et al. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 9, 234–242 (2006). source
Not checked in the free run.
- cites [70] Penzes, P., et al. Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron 37, 263–274 (2003). source
Not checked in the free run.
May combine two claims.
PremisecitationCalcineurin is a calcium-sensitive phosphatase involved in synaptic plasticity whose activation leads to synaptic weakening, and Alzheimer's disease-related pathology increases activation of GSK-3β.
“Calcineurin (CaN or PP2B) is a calcium-sensitive phosphatase involved in synaptic plasticity whose activation leads to synaptic weakening and Alzheimer’s disease–related pathology has been shown to increase activation of GSK-3β, a downstream effector molecule of calcineurin74,75.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [74] Li, S. et al. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788–801 (2009). source
Not checked in the free run.
- cites [75] Tackenberg, C. & Brandt, R. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J. Neurosci. 29, 14439–14450 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationKalrn knockout mice exhibit schizophrenia-related deficits in working memory, sociability, and prepulse inhibition.
“Notably, Kalrn−/− mice show severe reductions in spine density and dendrite complexity in the frontal cortex, as well as schizophrenia-related impairments in working memory, sociability and prepulse inhibition92,93.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [92] Cahill, M.E. et al. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl. Acad. Sci. USA 106, 13058–13063 (2009). source
Not checked in the free run.
- cites [93] Xie, Z., Cahill, M.E. & Penzes, P. Kalirin loss results in cortical morphological alterations. Mol. Cell. Neurosci. 43, 81–89 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationTg2576 mice express mutant human APP and have lower spine density in CA1 and dentate gyrus before amyloid plaques appear.
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [68] Lanz, T.A., Carter, D.B. & Merchant, K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 13, 246–253 (2003). source
Not checked in the free run.
- cites [95] Jacobsen, J.S. et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer′s disease. Proc. Natl. Acad. Sci. USA 103, 5161–5166 (2006). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationDiscrepancies between adult social approach tests, statistical analyses, and genetic background may explain the contradictory results between the two NLGN3-R451C mouse models.
“As suggested by the authors81, discrepancies between experimental designs of the adult social approach tests, statistical analyses and genetic background of the two mouse models may be the source of these contradictory results.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Chadman, K.K. et al. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 1, 147–158 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenVery little is known about spine morphology in ASD animal models.
“Surprisingly, however, very little is known about spine morphology in ASD animal models.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA hemizygous chromosomal deficiency mouse model of human 22q11.2 microdeletion displays schizophrenia-related behaviors: impaired working memory, hyperactivity, deficient sensory-motor gating, and impaired fear learning.
“Moreover, mice with a hemizygous chromosomal deficiency modeling the human 22q11.2 microdeletion syndrome have schizophrenia-related behavioral phenotypes, including impaired working memory, hyperactivity, deficient sensory-motor gating and impaired fear learning50.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Stark, K.L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationAβ reduces surface expression of NMDARs and AMPARs, and synaptotoxic effects of Aβ can be prevented by NMDAR antagonists.
“studies showing that Aβ reduces surface expression of NMDARs and AMPARs77,78 and others demonstrate synaptotoxic effects of Aβ can be prevented by NMDAR antagonists64.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [77] Hsieh, H. et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831–843 (2006). source
Not checked in the free run.
- cites [78] Snyder, E.M. et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051–1058 (2005). source
Not checked in the free run.
- cites [64] Shankar, G.M. et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor–dependent signaling pathway. J. Neurosci. 27, 2866–2875 (2007). source
Not checked in the free run.
May combine two claims.
PremisecitationIn in vitro and in vivo models of Alzheimer's disease, Aβ oligomers produce aberrant long-term potentiation expression and impair memory.
“Moreover, in vitro and in vivo models of Alzheimer’s disease, Aβ oligomers produce aberrant long-term potentiation expression and impair memory62.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Selkoe, D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106–113 (2008). source
Not checked in the free run.
May combine two claims.
Premisenone givenAberrant NMDAR activation can induce calcium signaling perturbations, and most signaling molecules discussed are downstream of NMDARs.
“Aberrant NMDAR activation can induce calcium signaling perturbations and, indeed, most of the signaling molecules discussed above are known to be downstream of NMDARs.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSpine loss and behavioral dysfunction both appeared during adolescence in Kalrn knockout mice.
“Both spine loss and behavioral dysfunction emerged during adolescence92.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Cahill, M.E. et al. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl. Acad. Sci. USA 106, 13058–13063 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationThe Df(16)A+/− mouse model of 22q11.2 microdeletion syndrome has reduced hippocampal spine density and spine size.
“Mice modeling the 22q11.2 microdeletion syndrome (Df(16)A+/−) show reduced hippocampal spine density and sizes51.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Mukai, J. et al. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 1302–1310 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationNLGN3-R451C transgenic mice display impaired social interaction, enhanced Morris water maze performance, and enhanced inhibitory synaptic strength.
“NLGN3-R451C transgenic mice display impaired social interaction behavior, but show enhanced performance in the Morris water maze, as well as enhanced inhibitory synaptic strength80.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76 (2007). source
Not checked in the free run.
May combine two claims.
PremisecitationZDHHC8-deficient mice have simplified dendritic trees and lower spine density.
“Mice deficient in individual genes in this region (ZDHHC8 and DGCR8) show simplified dendritic trees and reduced spine density51 or smaller spines50, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Mukai, J. et al. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 1302–1310 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationPharmacological and genetic manipulations have rescued both structural and behavioral phenotypes in PTEN, FMR1, and MECP2 knockout mice.
“Notably, pharmacological and genetic manipulations have successfully rescued both structural and behavioral phenotypes in PTEN86, FMR1 (ref. 87) and MECP2 (ref. 88) knockout mice.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [86] Zhou, J. et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J. Neurosci. 29, 1773–1783 (2009). source
Not checked in the free run.
- cites ref. 87
Not checked in the free run.
- cites ref. 88
Not checked in the free run.
May combine two claims.
PremisecitationNLGN4−/− knockout mice exhibit social interaction deficits and reduced ultrasonic vocalizations in response to a novel female, but dendritic spine morphology has not been analyzed.
“NLGN4−/− knockout mice exhibit social interaction deficits and reduced ultrasonic vocalizations in response to a novel female82, but, again, dendritic spine morphology has not been analyzed in this model.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] Jamain, S. et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. USA 105, 1710–1715 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationIndependently generated NLGN3-R451C transgenic mice have delayed developmental phenotypes, decreased ultrasonic vocalizations, slower righting reflexes, but no changes in social interaction or spatial learning.
“In contrast, independently generated NLGN3-R451C transgenic mice were observed to have delayed developmental phenotypes, such as decreased ultrasonic vocalizations and slower righting reflexes, but no changes were seen in social interaction or spatial learning as measured by Morris water maze81.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Chadman, K.K. et al. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 1, 147–158 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationMutant mice for NRG1 and ERBB4 display multiple schizophrenia-relevant behaviors; locomotor hyperactivity is consistently present and often responds to acute clozapine.
“NRG1 and ERBB4 mutant mice show several schizophrenia-relevant behavioral phenotypes, of which locomotor hyperactivity has been a consistent phenotype and can often be rescued through an acute dosage of the antipsychotic clozapine47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Mei, L. & Xiong, W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437–452 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningTherapies aimed at trophic and morphogenic signaling may be more effective, altering connectivity with fewer side effects.
“Indeed, many of the proteins in these pathways are enzymes that could be targeted with designer small molecules and drugs that target trophic and morphogenic signaling pathways may prove to be more effective, as they could alter cellular connectivity and induce fewer side effects.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningWithin these heterogeneous disorders, individuals with worse cognitive deficits may have more pronounced spine phenotypes.
“Given the heterogeneity of these complex disorders, some individuals may exhibit more marked spine phenotypes, particularly those with more severe cognitive deficits.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNear amyloid deposits, dendrites reportedly undergo shaft atrophy, neurite breakage, and greater spine density loss.
“Specifically, dendrites near amyloid deposits are reported to experience shaft atrophy, neurite breakage and greater reductions in spine density97.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97] Tsai, J., Grutzendler, J., Duff, K. & Gan, W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7, 1181–1183 (2004). source
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenMany proteins in these pathways are enzymes amenable to targeting by designer small molecules.
“Indeed, many of the proteins in these pathways are enzymes that could be targeted with designer small molecules and drugs that target trophic and morphogenic signaling pathways may prove to be more effective, as they could alter cellular connectivity and induce fewer side effects.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningEvidence that spine loss is an initial insult comes from Tg2576 mice and from genetic studies linking synaptic proteins to etiology.
“Support for the idea that spine loss is an initial insult comes from model mice, such as Tg2576, and from genetic studies that directly implicate synaptic proteins in etiology.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAPP/PS1 mutant mice have neurons with fewer large spines and dendritic abnormalities.
“Mice expressing mutations in both APP and PS1 yield neurons with diminished frequency of large spines and dendritic abnormalities96.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] Knafo, S. et al. Widespread changes in dendritic spines in a model of Alzheimer's disease. Cereb. Cortex 19, 586–592 (2009). source
Not checked in the free run.
May combine two claims.
Interpretationnone givenDisease-related spine changes affect synaptic function and circuit-level connectivity.
“Spine changes in disease have implications for both functional changes at the synapse and circuit-level connectivity, in the form of altered connectivity or changes in connection strength.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Most glutamatergic excitatory synapses in the mammalian forebrain occur on dendritic spines.
“In the mammalian forebrain, most glutamatergic excitatory synapses occur on small protrusions along dendrites called dendritic spines.”
The paper relies on this without support.
Changes in dendritic spine number and morphology accompany synapse formation, maintenance, and elimination during development and adulthood.
“During development and in adulthood, changes in dendritic spine number and morphology accompany synapse formation, maintenance and elimination, allowing the establishment and remodeling of connectivity within neuronal circuits.”
The paper relies on this without support.
Disease-specific disruptions in dendritic spine shape, size, or number accompany many brain disorders.
“Notably, disease-specific disruptions in dendritic spine shape, size or number accompany a large number of brain disorders, suggesting that dendritic spines may serve as a common substrate for many neuropsychiatric disorders, particularly those that involve deficits in information processing.”
The paper relies on this without support.
ASD, schizophrenia, and Alzheimer's disease are characterized by marked disruptions in information processing and cognition.
“ASD, schizophrenia and Alzheimer’s disease are neurological disorders that are characterized by marked disruptions in information processing and cognition”
The paper relies on this without support.
Symptoms of ASD, schizophrenia, and Alzheimer's disease manifest at distinct stages of life.
“Notably, the symptoms of each of these disorders manifest at distinct stages of life”
The paper relies on this without support.
Over 240 gene variants have been associated with schizophrenia.
“Over 240 gene variants have been associated with schizophrenia.”
The paper relies on this without support.
Alzheimer's disease can result from highly penetrant genetic mutations that faithfully give rise to the pathological hallmarks of the disease.
“Alzheimer’s disease can result from highly penetrant genetic mutations that faithfully give rise to the pathological hallmarks of the disease.”
The paper relies on this without support.
ASD is associated with local hyperconnectivity and long-range hypoconnectivity, whereas schizophrenia is associated with reduced short- and long-range connectivity.
“As ASD seems to be associated with local hyperconnectivity and long-range hypoconnectivity, whereas schizophrenia is associated with reduced short- and long-range connectivity, it would be of interest to determine the effects of disease genes and mutations on the growth and maintenance of dendrites and axons to address changes in circuit organization in these disease states.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Precocious brain development was previously associated with specific forms of NDD, including ASD.
“Precocious brain development was previously associated with specific forms of NDD, including ASD,11,61 and in vitro PSC models have recently suggested altered timing of neuronal differentiation in some forms of ASD.62”
From Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition (2024) · cites this paper as [61]
The Genetics and molecular mechanisms section links autism with PTEN mutations associated with macroencephaly and reports dendritic hypertrophy with PTEN deficiency. It does not establish that brain development occurs precociously or identify an accelerated developmental timetable in ASD. Page numbers are unavailable in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measuredDisruption in dendritic morphogenesis, synaptogenesis or activity-dependent remodelling produces network-wide deficits in neuronal connectivity.
“A disruption in any of these processes produces network-wide deficits in neuronal connectivity”
From The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines (2014) · cites this paper as [17]
The Abstract (page unavailable) says spine changes help establish and remodel circuit connectivity and may markedly affect connectivity patterns. The Conclusions and future directions (page unavailable) links disease-related spine changes to altered circuit-level connectivity. Neither passage establishes that disruption of any one of the three named processes necessarily produces network-wide deficits; the claim makes the effect more categorical and extensive than the paper does. (LLM, conf=0.84)
Experimental — accuracy not yet measuredChanges in morphological complexity, dendritic spine number, shape and plasticity are associated with several neuropsychiatric and neurological disorders, including schizophrenia, autism spectrum disorder, intellectual disability and epilepsy.
“changes in morphological complexity, dendritic spine number, shape and plasticity are associated with several neuropsychiatric and neurological disorders, including SCZ, ASD, ID and epilepsy.16, 17, 18, 19”
From The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines (2014) · cites this paper as [17]
The Abstract and ‘Neuropathological studies of spine morphology’ section associate changes in spine number and morphology with schizophrenia and ASD, and the latter also notes spine alterations in disorders historically termed mental retardation. The ‘Conclusions and future directions’ section mentions epilepsy as a comorbidity of ASD, but does not establish the claimed association between epilepsy itself and changes in dendritic spines. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThis interpretation is supported by a large number of researchers who study dendritic spine alterations both in humans and animal models.
“This interpretation is also supported by a large number of researchers who study dendritic spine alterations both in humans and animal models (see Penzes et al., 2011; Spires-Jones and Knafo, 2012 for recent reviews).”
From The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease (2013) · cites this paper as Penzes et al., 2011
These disorders are synaptopathies in which dysgenesis of dendritic spines is a recurrent anatomical feature.
“These disorders are synaptopathies (Ehninger and Silva, 2009) in which dysgenesis of dendritic spines is a recurrent anatomical feature (Penzes et al., 2011).”
From CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation (2013) · cites this paper as Penzes et al., 2011
Dendritic spine maturation is critical for correct brain functioning.
“Dendritic spine maturation is critical for correct brain functioning (Penzes et al., 2011).”
From CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation (2013) · cites this paper as Penzes et al., 2011
Spine dysmorphogenesis is a common feature of several neuropsychiatric disorders.
“Spine dysmorphogenesis is a common feature of several neuropsychiatric disorders (Penzes et al., 2011).”
From CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation (2013) · cites this paper as Penzes et al., 2011
Aberrations in spine density and morphology are associated with a number of neurological disorders, including Alzheimer's disease.
“Aberrations in spine density and morphology are associated with a number of neurological disorders, including Alzheimer's disease (AD) [15], [16], [17].”
From Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development (2012) · cites this paper as [15]
Spine loss is strongly correlated with cognitive impairments in AD.
“As spine loss is strongly correlated with cognitive impairments in AD [15], [66]”
From Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development (2012) · cites this paper as [15]
These pathways are also dysregulated in ASD.
“These are pathways that are also dysregulated in ASD [ 27 , 105 , 123 ].”
From DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? (2016) · cites this paper as [123]
Variation in the assembly and dynamic maintenance of specific neural circuits, primarily in the cerebral cortex and subcortical structures such as the basal ganglia and the amygdala, are at the core of psychiatric disease.
“Increasing evidence suggests that variation in the assembly and dynamic maintenance of specific neural circuits, primarily in the cerebral cortex and subcortical structures such as the basal ganglia and the amygdala, are at the core of psychiatric disease 20-23 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [22]
Dendritic spine density peaks in early childhood and declines steeply during late childhood and adolescence to adult levels, providing selection and maturation of synapses and neural circuits.
“Consistently, the density of dendritic spines peaks in early childhood and is followed by a steep decline during late childhood and adolescence to adult levels (Penzes et al., 2011), a process that provides selection and maturation of synapses and neural circuits.”
From Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits (2014) · cites this paper as Penzes et al., 2011
Spine type distributions shift with neuronal activity, aging, and disease processes.
“the distribution of various spine types, which changes in response to neuronal activity, aging or disease pathology”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [280]
There is growing consensus that spine abnormality is associated with behavioral deficiency and decline in cognitive functions.
“There is growing consensus that spine abnormality is associated with behavioral deficiency and decline in cognitive functions (for detail see Fiala et al., 2002; Penzes et al., 2011).”
From Spatiotemporal dynamics of dendritic spines in the living brain (2014) · cites this paper as Penzes et al., 2011
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,949 · see citing works
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · see citing works
Functional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1× · see citing works
“Several molecular and genetic themes in ASD synaptic pathology are emerging that include small GTPase and adhesion-related signaling pathway”
BackgroundExperience-dependent structural synaptic plasticity in the mammalian brain
Holtmaat, A., & Svoboda, K. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2699 · Cited by 1,934 · see citing works
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · see citing works
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · see citing works
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800 · see citing works
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · see citing works
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636 · see citing works
Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · see citing works
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · see citing works
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · see citing works
Behavioural phenotyping assays for mouse models of autism
Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462 · see citing works
Autism spectrum disorders: developmental disconnection syndromes
Geschwind, D. H., & Levitt, P. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.009 · Cited by 1,411 · see citing works
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230 · see citing works
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · see citing works
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · see citing works
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042 · see citing works
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038 · see citing works
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Mei, L., & Xiong, W.-C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2392 · Cited by 1,030 · see citing works
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997 · see citing works
Genetic Heterogeneity in Human Disease
McClellan, J., & King, M.-C. (2010) · Cell · doi:10.1016/j.cell.2010.03.032 · Cited by 981 · see citing works
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · see citing works
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972 · see citing works
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970 · see citing works
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917 · see citing works
The reduced neuropil hypothesis: a circuit based model of schizophrenia
Selemon, L. D., & Goldman-Rakic, P. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00281-9 · Cited by 909 · see citing works
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · see citing works
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832 · see citing works
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
Fiala, J. C., Spacek, J., & Harris, K. M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00158-3 · Cited by 811 · see citing works
Structural dynamics of dendritic spines in memory and cognition
Kasai, H., Fukuda, M., Watanabe, S., Hayashi-Takagi, A., & Noguchi, J. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.01.001 · Cited by 804 · see citing works
Butler, M. G., Dasouki, M. J., Zhou, X.-P., Talebizadeh, Z., Brown, M., Takahashi, T. N., Miles, J. H., Wang, C. H., Stratton, R., Pilarski, R., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024646 · Cited by 778 · see citing works
Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders
Hutsler, J. J., & Zhang, H. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.120 · Cited by 765 · see citing works
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747 · see citing works
Dendritic Anomalies in Disorders Associated with Mental Retardation
Kaufmann, W. E. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.981 · Cited by 733 · see citing works
Association within a family of a balanced autosomal translocation with major mental illness
St Clair, D., Blackwood, D., Muir, W., Walker, M., St Clair, D., Muir, W., Carothers, A., Spowart, G., Gosden, C., & Evans, H. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91520-k · Cited by 727 · see citing works
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701 · see citing works
Synaptogenesis in the Prefrontal Cortex of Rhesus Monkeys
Bourgeois, J.-P., Goldman-Rakic, P. S., & Rakic, P. (1994) · Cerebral Cortex · doi:10.1093/cercor/4.1.78 · Cited by 687 · see citing works
Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model
Stark, K. L., Xu, B., Bagchi, A., Lai, W.-S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A. A., Karayiorgou, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.138 · Cited by 648 · see citing works
(1997) · PubMed · Cited by 645 · see citing works
Bourgeron, T. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.06.003 · Cited by 637 · cited 1× · see citing works
“and Shank3 may complex with and signal downstream of NLGN”
BackgroundMutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation
Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.589 · Cited by 563 · see citing works
Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561 · see citing works
Jamain, S., Radyushkin, K., Hammerschmidt, K., Granon, S., Boretius, S., Varoqueaux, F., Ramanantsoa, N., Gallego, J., Ronnenberg, A., Winter, D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711555105 · Cited by 556 · see citing works
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · see citing works
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511 · see citing works
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497 · see citing works
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475 · see citing works
Penzes, P., Beeser, A., Chernoff, J., Schiller, M. R., Eipper, B. A., Mains, R. E., & Huganir, R. L. (2003) · Neuron · doi:10.1016/s0896-6273(02)01168-6 · Cited by 466 · see citing works
Self-citationZhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell, C. M., & Parada, L. F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5685-08.2009 · Cited by 441 · see citing works
Dindot, S. V., Antalffy, B. A., Bhattacharjee, M. B., & Beaudet, A. L. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm288 · Cited by 418 · see citing works
The role of epilepsy and epileptiform EEGs in autism spectrum disorders
Spence, S. J., & Schneider, M. T. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7168 · Cited by 418 · see citing works
Probing the biology of Alzheimer’s disease in mice
Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413 · see citing works
Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1
Hayashi-Takagi, A., Takaki, M., Graziane, N., Seshadri, S., Murdoch, H., Dunlop, A. J., Makino, Y., Seshadri, A. J., Ishizuka, K., Srivastava, D. P., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2487 · Cited by 399 · see citing works
Self-citationKalirin-7 Controls Activity-Dependent Structural and Functional Plasticity of Dendritic Spines
Xie, Z., Srivastava, D. P., Photowala, H., Kai, L., Cahill, M. E., Woolfrey, K. M., Shum, C. Y., Surmeier, D. J., & Penzes, P. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.005 · Cited by 373 · see citing works
Self-citationWu, H.-Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z., Spires-Jones, T., Xie, H., Arbel-Ornath, M., Grosskreutz, C. L., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-09.2010 · Cited by 367 · see citing works
The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity
Li, B., Woo, R.-S., Mei, L., & Malinow, R. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.028 · Cited by 354 · see citing works
Key role for gene dosage and synaptic homeostasis in autism spectrum disorders
Toro, R., Konyukh, M., Delorme, R., Leblond, C., Chaste, P., Fauchereau, F., Coleman, M., Leboyer, M., Gillberg, C., & Bourgeron, T. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.007 · Cited by 331 · see citing works
Ube3a is required for experience-dependent maturation of the neocortex
Yashiro, K., Riday, T. T., Condon, K. H., Roberts, A. C., Bernardo, D. R., Prakash, R., Weinberg, R. J., Ehlers, M. D., & Philpot, B. D. (2009) · Nature Neuroscience · doi:10.1038/nn.2327 · Cited by 328 · see citing works
Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1630 · Cited by 317 · see citing works
Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease
Knobloch, M., & Mansuy, I. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8018-z · Cited by 296 · see citing works
Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons
Roussignol, G., Ango, F., Romorini, S., Tu, J. C., Sala, C., Worley, P. F., Bockaert, J., & Fagni, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4354-04.2005 · Cited by 293 · see citing works
Minimal aberrant behavioral phenotypes of neuroligin‐3 R451C knockin mice
Chadman, K. K., Gong, S., Scattoni, M. L., Boltuck, S. E., Gandhy, S. U., Heintz, N., & Crawley, J. N. (2008) · Autism Research · doi:10.1002/aur.22 · Cited by 292 · see citing works
Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia
Sweet, R. A., Henteleff, R. A., Zhang, W., Sampson, A. R., & Lewis, D. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.67 · Cited by 290 · see citing works
The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses
Garcia, R. A. G., Vasudevan, K., & Buonanno, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3596 · Cited by 278 · see citing works
Irwin, S. A., Idupulapati, M., Gilbert, M. E., Harris, J. B., Chakravarti, A. B., Rogers, E. J., Crisostomo, R. A., Larsen, B. P., Mehta, A., Alcantara, C. J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10500 · Cited by 270 · see citing works
Kvajo, M., McKellar, H., Arguello, P. A., Drew, L. J., Moore, H., MacDermott, A. B., Karayiorgou, M., & Gogos, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802615105 · Cited by 268 · see citing works
Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm069 · Cited by 266 · see citing works
Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion
Mukai, J., Dhilla, A., Drew, L. J., Stark, K. L., Cao, L., MacDermott, A. B., Karayiorgou, M., & Gogos, J. A. (2008) · Nature Neuroscience · doi:10.1038/nn.2204 · Cited by 260 · see citing works
Steiner, P., Higley, M. J., Xu, W., Czervionke, B. L., Malenka, R. C., & Sabatini, B. L. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.014 · Cited by 259 · see citing works
Disorder-associated mutations lead to functional inactivation of neuroligins
Chih, B., Afridi, S. K., Clark, L., & Scheiffele, P. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh158 · Cited by 242 · see citing works
Kolluri, N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1200 · Cited by 241 · see citing works
Reversal of long-term dendritic spine alterations in Alzheimer disease models
Smith, D. L., Pozueta, J., Gong, B., Arancio, O., & Shelanski, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908706106 · Cited by 229 · see citing works
Norris, C. M., Kadish, I., Blalock, E. M., Chen, K.-C., Thibault, V., Porter, N. M., Landfield, P. W., & Kraner, S. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0365-05.2005 · Cited by 229 · see citing works
Hill, J. J., Hashimoto, T., & Lewis, D. A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001792 · Cited by 228 · see citing works
Lanz, T. A., Carter, D. B., & Merchant, K. M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00079-2 · Cited by 227 · see citing works
Kristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001844 · Cited by 220 · see citing works
ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons<i>In Vivo</i>
Dumanis, S. B., Tesoriero, J. A., Babus, L. W., Nguyen, M. T., Trotter, J. H., Ladu, M. J., Weeber, E. J., Turner, R. S., Xu, B., Rebeck, G. W., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4026-09.2009 · Cited by 220 · see citing works
Fraser, M. M., Bayazitov, I. T., Zakharenko, S. S., & Baker, S. J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.048 · Cited by 202 · see citing works
Barros, C. S., Calabrese, B., Chamero, P., Roberts, A. J., Korzus, E., Lloyd, K., Stowers, L., Mayford, M., Halpain, S., & Müller, U. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900355106 · Cited by 197 · see citing works
Ji, Y., Gong, Y., Gan, W., Beach, T., Holtzman, D. M., & Wisniewski, T. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.007 · Cited by 189 · see citing works
Chen, Y.-J. J., Johnson, M. A., Lieberman, M. D., Goodchild, R. E., Schobel, S., Lewandowski, N., Rosoklija, G., Liu, R.-C., Gingrich, J. A., Small, S., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1815-08.2008 · Cited by 188 · see citing works
Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes
Cahill, M. E., Xie, Z., Day, M., Photowala, H., Barbolina, M. V., Miller, C. A., Weiss, C., Radulovic, J., Sweatt, J. D., Disterhoft, J. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904636106 · Cited by 170 · see citing works
Self-citationExpression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs
Lipska, B. K., Peters, T., Hyde, T. M., Halim, N., Horowitz, C., Mitkus, S., Weickert, C. S., Matsumoto, M., Sawa, A., Straub, R. E., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl040 · Cited by 168 · see citing works
Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines
Woolfrey, K. M., Srivastava, D. P., Photowala, H., Yamashita, M., Barbolina, M. V., Cahill, M. E., Xie, Z., Jones, K. A., Quilliam, L. A., Prakriya, M., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2386 · Cited by 161 · see citing works
Self-citationKolomeets, N. S., Orlovskaya, D. D., Rachmanova, V. I., & Uranova, N. A. (2005) · Synapse · doi:10.1002/syn.20153 · Cited by 149 · see citing works
Ayhan, Y., Abazyan, B., Nomura, J., Kim, R., Ladenheim, B., Krasnova, I. N., Sawa, A., Margolis, R. L., Cadet, J. L., Mori, S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.144 · Cited by 148 · see citing works
Widespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
Knafo, S., Alonso-Nanclares, L., Gonzalez-Soriano, J., Merino-Serrais, P., Fernaud-Espinosa, I., Ferrer, I., & DeFelipe, J. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn111 · Cited by 132 · see citing works
The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects
Sleegers, K., Lambert, J.-C., Bertram, L., Cruts, M., Amouyel, P., & Van Broeckhoven, C. (2010) · Trends in Genetics · doi:10.1016/j.tig.2009.12.004 · Cited by 129 · see citing works
Tackenberg, C., & Brandt, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3590-09.2009 · Cited by 127 · see citing works
Gogtay, N. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm103 · Cited by 124 · see citing works
Bacchelli, E., Blasi, F., Biondolillo, M., Lamb, J. A., Bonora, E., Barnby, G., Parr, J., Beyer, K. S., Klauck, S. M., Poustka, A., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001340 · Cited by 117 · see citing works
Thin, Stubby or Mushroom: Spine Pathology in Alzheimers Disease
Tackenberg, C., Ghori, A., & Brandt, R. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486554 · Cited by 112 · see citing works
Deletion of α‐neurexins does not cause a major impairment of axonal pathfinding or synapse formation
Dudanova, I., Tabuchi, K., Rohlmann, A., Südhof, T. C., & Missler, M. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21305 · Cited by 98 · see citing works
Kushima, I., Nakamura, Y., Aleksic, B., Ikeda, M., Ito, Y., Shiino, T., Okochi, T., Fukuo, Y., Ujike, H., Suzuki, M., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq118 · Cited by 92 · see citing works
Schumacher, J., Laje, G., Jamra, R. A., Becker, T., Mühleisen, T. W., Vasilescu, C., Mattheisen, M., Herms, S., Hoffmann, P., Hillmer, A. M., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp204 · Cited by 86 · see citing works
Kalirin is Under-Expressed in Alzheimer's Disease Hippocampus
Youn, H., Jeoung, M., Koo, Y., Ji, H., Markesbery, W. R., Ji, I., & Ji, T. H. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11314 · Cited by 77 · see citing works
Yoshida, T., McCarley, R. W., Nakamura, M., Lee, K., Koo, M.-S., Bouix, S., Salisbury, D. F., Morra, L., Shenton, M. E., & Niznikiewicz, M. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.004 · Cited by 74 · see citing works
Kalirin loss results in cortical morphological alterations
Xie, Z., Cahill, M. E., & Penzes, P. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.09.006 · Cited by 56 · see citing works
Self-citationIrwin (2001) · doi:10.1002/1096-8628(20010115)98:2
Flagged first, then by citations
Cited by
Sorted by citations
Synaptic, transcriptional and chromatin genes disrupted in autism
Study, T. D., De Rubeis, S., Autism, H. M. C. F., UK10K Consortium, The Autism Sequencing Consortium, He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., et al. (2014) · Nature · doi:10.1038/nature13772 · Cited by 2,746 · see citing works
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767 · see citing works
Extraordinary neoteny of synaptic spines in the human prefrontal cortex
Petanjek, Z., Judaš, M., Šimić, G., Rašin, M. R., Uylings, H. B. M., Rakic, P., & Kostović, I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105108108 · Cited by 1,411 · see citing works
Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits
Tang, G., Gudsnuk, K., Kuo, S.-H., Cotrina, M. L., Rosoklija, G., Sosunov, A., Sonders, M. S., Kanter, E., Castagna, C., Yamamoto, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.040 · Cited by 1,146 · see citing works
Microglia contact induces synapse formation in developing somatosensory cortex
Miyamoto, A., Wake, H., Ishikawa, A. W., Eto, K., Shibata, K., Murakoshi, H., Koizumi, S., Moorhouse, A. J., Yoshimura, Y., & Nabekura, J. (2016) · Nature Communications · doi:10.1038/ncomms12540 · Cited by 649 · see citing works
Sloan, S. A., Darmanis, S., Huber, N., Khan, T. A., Birey, F., Caneda, C., Reimer, R., Quake, S. R., Barres, B. A., & Paşca, S. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.035 · Cited by 593 · see citing works
Dendritic spine pathology in schizophrenia
Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581 · see citing works
Autism spectrum disorder: neuropathology and animal models
Varghese, M., Keshav, N., Jacot-Descombes, S., Warda, T., Wicinski, B., Dickstein, D. L., Harony-Nicolas, H., De Rubeis, S., Drapeau, E., Buxbaum, J. D., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1736-4 · Cited by 536 · see citing works
Gao, R., & Penzes, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303003028 · Cited by 516 · see citing works
“ASDs are a group of neurodevelopmental disorders characterized by repetitive behaviors and problems with social interaction and communication while SCZ is a disease afflicting thought, perceptions of reality, affect, and cognition [2].”
BackgroundSelf-citationAltering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516 · see citing works
Dendritic structural plasticity and neuropsychiatric disease
Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464 · see citing works
Self-citationStructural plasticity upon learning: regulation and functions
Caroni, P., Donato, F., & Muller, D. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3258 · Cited by 491 · see citing works
Microglia: actively surveying and shaping neuronal circuit structure and function
Wake, H., Moorhouse, A. J., Miyamoto, A., & Nabekura, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.007 · Cited by 448 · see citing works
Clement, J. P., Aceti, M., Creson, T. K., Ozkan, E. D., Shi, Y., Reish, N. J., Almonte, A. G., Miller, B. H., Wiltgen, B. J., Miller, C. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.045 · Cited by 385 · see citing works
Developmental timing and critical windows for the treatment of psychiatric disorders
Marín, O. (2016) · Nature Medicine · doi:10.1038/nm.4225 · Cited by 374 · see citing works
Do glia drive synaptic and cognitive impairment in disease?
Chung, W.-S., Welsh, C. A., Barres, B. A., & Stevens, B. (2015) · Nature Neuroscience · doi:10.1038/nn.4142 · Cited by 385 · see citing works
Altered neural connectivity in excitatory and inhibitory cortical circuits in autism
Zikopoulos, B., & Barbas, H. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00609 · Cited by 313 · see citing works
Structural and synaptic plasticity in stress-related disorders
Christoffel, D. J., Golden, S. A., & Russo, S. J. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.044 · Cited by 334 · see citing works
Astrocytic abnormalities and global DNA methylation patterns in depression and suicide
Nagy, C., Suderman, M., Yang, J., Szyf, M., Mechawar, N., Ernst, C., & Turecki, G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.21 · Cited by 301 · see citing works
Neuroinflammation in schizophrenia especially focused on the role of microglia
Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314 · see citing works
De Rubeis, S., Pasciuto, E., Li, K. W., Fernández, E., Di Marino, D., Buzzi, A., Ostroff, L. E., Klann, E., Zwartkruis, F. J. T., Komiyama, N. H., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.039 · Cited by 296 · see citing works
Stress, anxiety, and dendritic spines: What are the connections?
Leuner, B., & Shors, T. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.021 · Cited by 284 · see citing works
Ribierre, T., Deleuze, C., Bacq, A., Baldassari, S., Marsan, E., Chipaux, M., Muraca, G., Roussel, D., Navarro, V., Leguern, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99384 · Cited by 241 · see citing works
Analyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235 · see citing works
A Quantitative Framework to Evaluate Modeling of Cortical Development by Neural Stem Cells
Stein, J. L., de la Torre-Ubieta, L., Tian, Y., Parikshak, N. N., Hernández, I. A., Marchetto, M. C., Baker, D. K., Lu, D., Hinman, C. R., Lowe, J. K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.035 · Cited by 201 · see citing works
Developmental origins of brain disorders: roles for dopamine
Money, K. M., & Stanwood, G. D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00260 · Cited by 221 · see citing works
Brain adaptation and alternative developmental trajectories
Johnson, M. H., Jones, E. J. H., & Gliga, T. (2015) · Development and Psychopathology · doi:10.1017/s0954579415000073 · Cited by 213 · see citing works
Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies
Suzuki, H., Ohgidani, M., Kuwano, N., Chrétien, F., Lorin de la Grandmaison, G., Onaya, M., Tominaga, I., Setoyama, D., Kang, D., Mimura, M., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00031 · Cited by 198 · see citing works
Diverse types of genetic variation converge on functional gene networks involved in schizophrenia
Gilman, S. R., Chang, J., Xu, B., Bawa, T. S., Gogos, J. A., Karayiorgou, M., & Vitkup, D. (2012) · Nature Neuroscience · doi:10.1038/nn.3261 · Cited by 200 · see citing works
PTEN signaling in autism spectrum disorders
Zhou, J., & Parada, L. F. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.05.004 · Cited by 188 · see citing works
Pathania, M., Davenport, E. C., Muir, J., Sheehan, D. F., López-Doménech, G., & Kittler, J. T. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.16 · Cited by 189 · see citing works
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167 · see citing works
Twenty Years of SynGAP Research: From Synapses to Cognition
Gamache, T. R., Araki, Y., & Huganir, R. L. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0420-19.2020 · Cited by 161 · see citing works
Changes in Cortical Plasticity Across the Lifespan
Freitas, C., Perez, J., Knobel, M., Tormos, J. M., Oberman, L., Eldaief, M., Bashir, S., Vernet, M., Peña-Gómez, C., & Pascual-Leone, A. (2011) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2011.00005 · Cited by 172 · see citing works
Developmental mechanisms underlying the evolution of human cortical circuits
Vanderhaeghen, P., & Polleux, F. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00675-z · Cited by 173 · see citing works
Maternal immune activation in neurodevelopmental disorders
Solek, C. M., Farooqi, N., Verly, M., Lim, T. K., & Ruthazer, E. S. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24612 · Cited by 168 · see citing works
Keil, K. P., & Lein, P. J. (2016) · Environmental Epigenetics · doi:10.1093/eep/dvv012 · Cited by 167 · see citing works
Wnts in adult brain: from synaptic plasticity to cognitive deficiencies
Oliva, C. A., Vargas, J. Y., & Inestrosa, N. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00224 · Cited by 162 · see citing works
Berkel, S., Tang, W., Treviño, M., Vogt, M., Obenhaus, H. A., Gass, P., Scherer, S. W., Sprengel, R., Schratt, G., & Rappold, G. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr470 · Cited by 162 · see citing works
AMPA receptors as drug targets in neurological disease—advantages, caveats, and future outlook
Chang, P. K. ‐., Verbich, D., & McKinney, R. A. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08165.x · Cited by 155 · see citing works
Enhanced synapse remodelling as a common phenotype in mouse models of autism
Isshiki, M., Tanaka, S., Kuriu, T., Tabuchi, K., Takumi, T., & Okabe, S. (2014) · Nature Communications · doi:10.1038/ncomms5742 · Cited by 152 · see citing works
Intrinsic functional connectivity variance and state‐specific under‐connectivity in autism
Chen, H., Nomi, J. S., Uddin, L. Q., Duan, X., & Chen, H. (2017) · Human Brain Mapping · doi:10.1002/hbm.23764 · Cited by 137 · see citing works
PCB-95 Promotes Dendritic Growth via Ryanodine Receptor–Dependent Mechanisms
Wayman, G. A., Yang, D., Bose, D. D., Lesiak, A., Ledoux, V., Bruun, D., Pessah, I. N., & Lein, P. J. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104832 · Cited by 136 · see citing works
Aceti, M., Creson, T. K., Vaissiere, T., Rojas, C., Huang, W.-C., Wang, Y.-X., Petralia, R. S., Page, D. T., Miller, C. A., & Rumbaugh, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.001 · Cited by 129 · see citing works
Merino-Serrais, P., Benavides-Piccione, R., Blazquez-Llorca, L., Kastanauskaite, A., Rábano, A., Avila, J., & DeFelipe, J. (2013) · Brain · doi:10.1093/brain/awt088 · Cited by 134 · see citing works
Jiang, M., Ash, R. T., Baker, S. A., Suter, B., Ferguson, A., Park, J., Rudy, J., Torsky, S. P., Chao, H.-T., Zoghbi, H. Y., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1745-13.2013 · Cited by 129 · see citing works
Iafrati, J., Orejarena, M. J., Lassalle, O., Bouamrane, L., & Chavis, P. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.66 · Cited by 132 · see citing works
Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine
Kim, I. H., Rossi, M. A., Aryal, D. K., Racz, B., Kim, N., Uezu, A., Wang, F., Wetsel, W. C., Weinberg, R. J., Yin, H., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4015 · Cited by 127 · see citing works
Wagnon, J. L., Briese, M., Sun, W., Mahaffey, C. L., Curk, T., Rot, G., Ule, J., & Frankel, W. N. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003067 · Cited by 125 · see citing works
Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders
Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125 · see citing works
Self-citationThe emerging role of microRNAs in schizophrenia and autism spectrum disorders
Mellios, N., & Sur, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00039 · Cited by 120 · see citing works
Specific Glial Functions Contribute to Schizophrenia Susceptibility
Goudriaan, A., de Leeuw, C., Ripke, S., Hultman, C. M., Sklar, P., Sullivan, P. F., Smit, A. B., Posthuma, D., & Verheijen, M. H. G. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt109 · Cited by 114 · see citing works
Chen, Y., Kramár, E. A., Chen, L. Y., Babayan, A. H., Andres, A. L., Gall, C. M., Lynch, G., & Baram, T. Z. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.17 · Cited by 115 · see citing works
Prata, J., Santos, S. G., Almeida, M. I., Coelho, R., & Barbosa, M. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0938-y · Cited by 115 · see citing works
de Bartolomeis, A., Barone, A., Vellucci, L., Mazza, B., Austin, M. C., Iasevoli, F., & Ciccarelli, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02976-3 · Cited by 113 · see citing works
Coiro, P., Padmashri, R., Suresh, A., Spartz, E., Pendyala, G., Chou, S., Jung, Y., Meays, B., Roy, S., Gautam, N., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.022 · Cited by 105 · see citing works
Keith, D. J., Sanderson, J. L., Gibson, E. S., Woolfrey, K. M., Robertson, H. R., Olszewski, K., Kang, R., El-Husseini, A., & Dell'Acqua, M. L. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0784-12.2012 · Cited by 108 · see citing works
Self-citationThe microbiota–microglia axis in central nervous system disorders
Mossad, O., & Erny, D. (2020) · Brain Pathology · doi:10.1111/bpa.12908 · Cited by 98 · see citing works
Review: Cortical construction in autism spectrum disorder: columns, connectivity and the subplate
Hutsler, J. J., & Casanova, M. F. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12227 · Cited by 94 · see citing works
Vojtechova, I., Machacek, T., Kristofikova, Z., Stuchlik, A., & Petrasek, T. (2022) · PLOS Pathogens · doi:10.1371/journal.ppat.1010929 · Cited by 92 · see citing works
Szepesi, Z., Hosy, E., Ruszczycki, B., Bijata, M., Pyskaty, M., Bikbaev, A., Heine, M., Choquet, D., Kaczmarek, L., & Wlodarczyk, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098274 · Cited by 83 · see citing works
Spatiotemporal dynamics of dendritic spines in the living brain
Chen, C.-C., Lu, J., & Zuo, Y. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00028 · Cited by 88 · see citing works
Ng, L. H. L., Huang, Y., Han, L., Chang, R. C.-C., Chan, Y. S., & Lai, C. S. W. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0321-5 · Cited by 82 · see citing works
Hung, Y.-F., Chen, C.-Y., Shih, Y.-C., Liu, H.-Y., Huang, C.-M., & Hsueh, Y.-P. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201712113 · Cited by 86 · see citing works
Blizinsky, K. D., Diaz-Castro, B., Forrest, M. P., Schürmann, B., Bach, A. P., Martin-de-Saavedra, M. D., Wang, L., Csernansky, J. G., Duan, J., & Penzes, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607014113 · Cited by 76 · see citing works
Self-citationDonegan, J. J., Girotti, M., Weinberg, M. S., & Morilak, D. A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3968-13.2014 · Cited by 77 · see citing works
Schürmann, B., Bermingham, D. P., Kopeikina, K. J., Myczek, K., Yoon, S., Horan, K. E., Kelly, C. J., Martin-de-Saavedra, M. D., Forrest, M. P., Fawcett-Patel, J. M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0407-3 · Cited by 72 · see citing works
Self-citationControl of dendritic spine morphological and functional plasticity by small GTPases.
Woolfrey, K. M., & Srivastava, D. P. (2016) · Neural Plasticity · doi:10.1155/2016/3025948 · Cited by 76 · see citing works
Self-citationKim, H., Kunz, P. A., Mooney, R., Philpot, B. D., & Smith, S. L. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.4204-15.2016 · Cited by 65 · see citing works
Khibnik, L. A., Beaumont, M., Doyle, M., Heshmati, M., Slesinger, P. A., Nestler, E. J., & Russo, S. J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.022 · Cited by 67 · see citing works
Khanal, P., & Hotulainen, P. (2021) · Cells · doi:10.3390/cells10092392 · Cited by 60 · see citing works
De Simone, G., Mazza, B., Vellucci, L., Barone, A., Ciccarelli, M., & de Bartolomeis, A. (2023) · Antioxidants · doi:10.3390/antiox12040975 · Cited by 49 · see citing works
de Bartolomeis, A., Buonaguro, E. F., Latte, G., Rossi, R., Marmo, F., Iasevoli, F., & Tomasetti, C. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00240 · Cited by 44 · see citing works
Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development
Jain, S., Yoon, S. Y., Zhu, L., Brodbeck, J., Dai, J., Walker, D., & Huang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046340 · Cited by 43 · see citing works
Lepeta, K., Purzycka, K. J., Pachulska‐Wieczorek, K., Mitjans, M., Begemann, M., Vafadari, B., Bijata, K., Adamiak, R. W., Ehrenreich, H., Dziembowska, M., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707723 · Cited by 39 · see citing works
Teter, O. M., McQuade, A., Hagan, V., Liang, W., Dräger, N. M., Sattler, S. M., Holmes, B. B., Castillo, V. C., Papakis, V., Leng, K., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02997-z · Cited by 38 · see citing works
Bucher, M., Niebling, S., Han, Y., Molodenskiy, D., Hassani Nia, F., Kreienkamp, H.-J., Svergun, D., Kim, E., Kostyukova, A. S., Kreutz, M. R., et al. (2021) · eLife · doi:10.7554/elife.66165 · Cited by 33 · see citing works
Developing new pharmacotherapies for autism
Ecker, C., Spooren, W., & Murphy, D. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12113 · Cited by 31 · see citing works
García-Cabezas, M. Á., Barbas, H., & Zikopoulos, B. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00070 · Cited by 30 · see citing works
Opposing Roles of apolipoprotein E in aging and neurodegeneration
Hudry, E., Klickstein, J., Cannavo, C., Jackson, R., Muzikansky, A., Gandhi, S., Urick, D., Sargent, T., Wrobleski, L., Roe, A. D., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900325 · Cited by 30 · see citing works
New therapeutic options for autism spectrum disorder: experimental evidences
Peñagarikano, O. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.301 · Cited by 24 · see citing works
Xie, Y.-C., Yao, Z.-H., Yao, X.-L., Pan, J.-Z., Zhang, S.-F., Zhang, Y., & Hu, J.-C. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180782 · Cited by 24 · see citing works
Libé-Philippot, B., Iwata, R., Recupero, A. J., Wierda, K., Bernal Garcia, S., Hammond, L., van Benthem, A., Limame, R., Ditkowska, M., Beckers, S., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.08.021 · Cited by 22 · see citing works
“…promote neoteny by upregulating the synaptic levels of SYNGAP1 in human CPNs. Precocious brain development was previously associated with specific forms of NDD, including ASD, 11,61 and in vitro PSC models have recently suggested altered timing of neuronal differentiation in some forms of ASD.”
BackgroundOptimization of cell morphology measurement via single-molecule tracking PALM
Frost, N. A., Lu, H. E., & Blanpied, T. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036751 · Cited by 22 · see citing works
Hrvoj-Mihic, B., Hanson, K. L., Lew, C. H., Stefanacci, L., Jacobs, B., Bellugi, U., & Semendeferi, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00419 · Cited by 21 · see citing works
Dong, J., Fu, H., Fu, Y., You, M., Li, X., Wang, C., Leng, K., Wang, Y., & Chen, J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00612 · Cited by 20 · see citing works
Falkovich, R., Aryal, S., Sheng, M., & Bathe, M. (2024) · doi:10.1101/2024.10.28.620504 · Cited by 2 · see citing works
- Authors
- Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Penzes, Peter
- Venue
- Nature Neuroscience
- Published
- 2011-02-23
- Volume
- 14
- Issue
- 3
- Pages
- 285-293
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC3530413
- OpenAlex
- W2040268226
- Cited by
- 1,523
- References
- 102
- Citations by year
- 2026: 67 · 2025: 74 · 2024: 94 · 2023: 90 · 2022: 105 · 2021: 123 · 2020: 120 · 2019: 114 · 2018: 97 · 2017: 120 · 2016: 110 · 2015: 104 · 2014: 105 · 2013: 83 · 2012: 85
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1f31mh087043-01a1)
- National Institute on Aging (F31AG031621)
- National Institute of Mental Health (MH071533, 1F31MH087043, MH 071316, R01MH071533, R56MH071316, F31 MH087043, F31MH085362, R01MH071316)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- dendritic spines, synaptic pathology, autism spectrum disorder, schizophrenia, Alzheimer's disease, neuropsychiatric disorders, neurodegenerative diseases, pathogenesis, endophenotypes, therapeutic target, animal models, reverse translation
- MeSH terms
- Alzheimer Disease, Animals, Humans, Nerve Tissue Proteins, Nervous System Diseases, Schizophrenia, Dendritic Spines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review